An orally bioavailable, ATP-competitive inhibitor of mutant V600E and wild type B-Raf kinases (IC50s = 31 and 100 nM, respectively); inhibits cell proliferation in a variety of cell lines expressing B-RafV600E and is effective against the growth of tumors bearing the B-RafV600E mutation.